23rd Apr 2025 A plain language summary of responses to common misconceptions relating to updated COVID-19 mRNA vaccines
23rd Apr 2025 Plain language summary of safety data on the BNT162b2 COVID-19 vaccine: development, approval and ongoing monitoring
22nd Jan 2025 Plain language summary of how COVID-19 treatment with ritonavir may interact with other medications
22nd Nov 2023 A plain language summary discussing whether the COVID-19 pandemic changed resistance to current antifungal medicines
1st Mar 2023 Plain language summary of Pfizer-BioNTech BNT162b2 vaccine protection against COVID-19 and its safety in participants 12- to 15-years-old
